We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
OSX | Osteopore Limited | 0.375 | 0.21 | 127.27% | 2,358,355 | 662 |
BCMO | Brazilian Critical Minerals Ltd | 0.005 | 0.002 | 66.67% | 4,928,274 | 9 |
RCR | Rincon Resources Limited | 0.045 | 0.012 | 36.36% | 21,918,190 | 323 |
SRT | Strata Investment Holdings plc | 0.19 | 0.05 | 35.71% | 70,932 | 8 |
M4MOB | Macro Metals Ltd | 0.004 | 0.001 | 33.33% | 200,000 | 2 |
E33 | East 33 Limited | 0.017 | 0.004 | 30.77% | 1,480,796 | 24 |
AUG | Augustus Minerals Ltd | 0.039 | 0.009 | 30.00% | 7,490,062 | 273 |
M4M | Macro Metals Ltd | 0.018 | 0.004 | 28.57% | 27,999,475 | 74 |
GTI | Gratifii Limited | 0.009 | 0.002 | 28.57% | 3,414,226 | 13 |
CHW | Chilwa Minerals Ltd | 0.395 | 0.085 | 27.42% | 177,350 | 17 |
IMUOD | Imugene Ltd | 0.005 | 0.001 | 25.00% | 117,761 | 12 |
ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has approved ANKTIVA (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.
Hibbett, Inc. (“Hibbett”) (Nasdaq:HIBB), an athletic-inspired fashion retailer, today announced a definitive agreement in which JD Sports Fashion plc (“JD Sports”) (LSE:JD) will acquire all outstanding shares of Hibbett for $87.50 per share in cash, representing an aggregate enterprise value of approximately $1.1 billion.
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that an abstract featuring new preclinical data highlighting ADI-270, an armored allogeneic “off-the-shelf” gamma delta CAR (chimeric antigen receptor) T cell therapy candidate targeting CD70 positive cancers, has been selected for an oral presentation at the ASGCT 27th Annual Meeting taking place from May 7-11, 2024, in Baltimore, MD. The oral presentation will take place on May 10, 2024 in the Targeted Gene and Cell Therapy session, co-chaired by Adicet Bio’s Chief Scientific Officer, ...
FY 2023: 5-year-record Revenues $26.6 million; EBITDA Growth of 2350%Q4 2023: Revenues $5.7 million; EBITDA $1.1 million; Non-GAAP EPS of $0.15 TEL AVIV, Israel , April 22, 2024 /PRNewswire/ -- SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT, and Cybersecurity sectors, today reported results for the twelve months and fourth quarter, ended December 31, 2023.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 66,183.05 | -674.90 | -1.01% | 1.3T | 3,490,758,953 |
ETH | Ethereum | 3,177.57 | -24.49 | -0.76% | 382.6B | 1,585,224,858 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 97.84B | 401,278,863 |
BNB | Binance Coin | 608.69 | 3.59 | 0.59% | 96.52B | 290,890,361 |
SOL | Solana | 154.79 | -2.22 | -1.41% | 68.45B | 1,058,557,339 |
STETH | stETH | 3,164.68 | -35.78 | -1.12% | 31.08B | 3,187,444 |
XRP | Ripple | 0.5452 | -0.0115 | -2.07% | 29.82B | 431,307,618 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 1,068,264,177 |
DOGE | Dogecoin | 0.1583 | -0.00293 | -1.82% | 22.75B | 378,617,130 |
TONCOIN | Wrapped TON Coin | 5.68 | -0.234244 | -3.96% | 19.72B | 129,435,595 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions